You are here: 




 


 






 

  • Affitech AS

    Business focus

    Affitech utilizes its unrivalled breadth of expertise in human antibody and target discovery to create therapeutic antibodies for the treatment of cancer, infectious disease, inflammation, and other diseases of unmet medical needs.

    Contact

    Gaustadalleen 21,
    NO-0349 Oslo
    Phone: +47 22 95 87 58
    FAX:      +47 22 95 83 58

    Contact: CEO Martin Welschof

  • Algeta ASA

    Business focus

    Algeta ASA, headquartered in Oslo, Norway, is a public therapeutics company dedicated to the development of novel anticancer therapeutics based on alpha-pharmaceuticals.

    Contact

    P.O.Box 54 Kjelsås,
    NO-0411 Oslo 
    Phone: +47 23 00 79 90
    Fax:       +47 23 00 79 91
    Contact: CEO Andrew Kay  

  • Algipharma AS

    Business focus

    The company is developing new medications and medical devices based on alginate polysaccharide technologies.

    Contact

    Industriveien 33,
    NO-1337 Sandvika
    Phone: +47 94 86 89 75 
    Fax:       +47 67 54 57 70

    Contact: Rolf Myrvold  

  • Aqualis

    Business focus

    Aqualis ASA is a Norwegian public company focusing on building a profitable and successful business based on its key competences within the marine and offshore and healthcare sectors.

    Contact

    Aqualis ASA
    Sjølyst Plass 2, 4th floor.
    NO-0278 Oslo
    Norway
    Phone: +47 23 01 49 90
    Contact: Ole Henrik Eriksen,
    Chief Business Officer Healthcare


     

  • AstraZeneca AS

    Business focus

    AstraZeneca develops and markets cost effective therapeutic solutions based on innovative medications to give people a better life.

    Contact

    Visiting address: Hoffsveien 70B, 
                                   NO-0377 OSLO
    Postal adress:    PO Box 200 Vindern,
                                   NO-0319 Oslo
    Phone: +47 21 00 64 00 
    Fax: + 21 00 64 01 
    Contact: Global Vice President MCCD Henrik Lund

  • Avexxin AS

    Business focus

    Avexxin is a pharmaceutical company focused on developing and commercializing novel small molecule therapeutics for patients with chronic inflammatory conditions.

    Contact

    Avvexin AS,
    Department of Biology,
    Norwegian University of Science and Technology,
    NO-7491 Trondheim 
    Phone: +47 73 59 61 07
    Contact: Professor Berit Johansen  

  • Axellia Pharmaceuticals AS

    Business focus

    Axellia is a leading producer of active pharmaceutical ingredients (APIs), specialised in fermented antibiotics and injectable finished products.

    Contact

    P.O. Box 158 Skøyen,
    NO-0212 Oslo 
    Phone: +47 22 52 92 46 / 902 08 233
    Fax:      +47 22 50 58 60 

    Contact: Patent Manager Marianne Nesje

  • Baxter International Inc.

    Business focus

    Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders,infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology tocreate products that advance patient care worldwide.

    Contact

    Baxter As
    Gjerdrums vei 11,
    NO-0486 Oslo
    Phone:+47 22 58 48 00
    Contact: Sverre Slaastad, Country Managing Director

  • Bio-Medisinsk Innovasjon AS

    Business focus

    The aim of Bio-Medisinsk Innovasjon AS is to increase the value of biomedical innovations in an early phase and develop projects to interesting investment objects for venture capital and industry. BMI cooperates with Oslo Innovation Center AS, Medinnova and the technology transfer office at the University of Oslo, Birkeland Innovasjon AS.

    Contact

    Gaustadalléen 21,
    NO-0349 OSLO.
    Phone: +47 22 95 81 90 / 93 41 17 14
    Fax:       +47 22 60 44 27 

    Contact: CEO Ingrid Alfheim

  • Bionor Pharma ASA

    Business focus

    Research and development of therapeutic HIV vaccines, Vacc-4x (to induce killing of HIV infected cells) and Vacc-C5 (to reduce hyper immune activation), and combination therapies. Technology platform also positioned to develop vaccines for other viral diseases, such as Influenza and Hepatitis C.

    Contact

    P.O. Box 1477 Vika,
    NO-0116 Oslo, Norway
    Tel. +47 23 01 09 60
    Contact: CEO Anker Lundemose

     

  • Biotec Pharmacon ASA

    Business focus

    Bioactive compounds which can modulate the innate immune system and thus prevent and treat diseases in humans and animals, and marine enzymes used in research and diagnostics.Biotec Pharmacon ASA is a biopharmaceutical company that develops new pharmaceutical products for treatment of immune related diseases.

    Contact

    Strandgt. 3,
    NO-9008 Tromsø.
    Phone: +47 77 64 89 00
    Fax:      +47 77 64 89 01

    Contact:  CEO Svein Lien

  • Borregaard Industrier Ltd

    Business focus

    Borregaard is a leading supplier of wood based specialty chemicals, a supplier of food and feed ingredients and pharmaceutical intermediates. Borregaard is manufacturing and supplying a wide range of products and chemicals from many plants in Europe, Africa, South-America, Noth-America and Asia. Borregaard's plants in Norway and Switzerland is claimed to be the most advanced biorefineries in operation in the world today. The pharmaceutical intermediate manufacturing equipment is cGMP certified.  
    Borregaard has since 2007 started development of biochemicals, biofuels, proteins and biomaterials from a wide range of 2nd generation biomasses (that is whithout competition with food production). 

    Contact

    P.O. Box 162
    NO-1701 Sarpsborg.
    Phone: +47 69 11 81 60
    Fax:       +47 69 11 86 40 

    Contact: Technology Director Business Development, Gudbrand Rødsrud  

  • Epitarget AS

    Business focus

    Epitarget AS is a privately owned Norwegian life science company dedicated to developing cancer therapies. In current chemotherapy the whole body is treated, not only the diseased parts. The company focuses on developing technology to deliver approved and established cancer drugs exactly where they are needed by means of ultrasound mediated drug release. The main product is ultrasound sensitive drug carrying particles. 

    Contact

    Pb 7159 Majorstuen,
    NO-0307 Oslo.
    Phone: +47 23 20 12 95
    Fax:       +47 23 20 12 49

    Contact: CEO Esben A. Nilssen 

  • FMC Biopolymer AS

    Business focus

    FMC Biopolymer AS is among the world’s largest alginate manufacturers and offers a full range of functionalities and capabilities to assist formulators in creating and launching innovative alginate based products and systems for pharmaceutical, industrial, and food applications.

    Contact

    Tomtegt. 36, P.O. Box 494 Brakerøya,
    NO-3002 Drammen.
    Phone: +47 32 20 35 29 / 415 09 623
    Fax:       +47 32 20 35 10

    Contact: Head of Alginate Research: Edvar Onsøyen, Ph.D

  • FürstNAT AS

    Business focus

    FürstNAT is a privately held laboratory in the Fürst consortium. FürstNAT offers high quality molecular biology diagnostic testing for routine and research use.

    Contact

    Søren Bullsv. 25
    NO-1051 Oslo
    Tel: +47 22 90 95 00
    Fax: +47 22 90 96 06
    Contact: Nils Reinton

  • GE Healthcare

    Business focus

    GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.

    GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries.

    Contact

    P.O. Box 4220 Nydalen,
    NO-0401 Oslo.
    Phone: +47 23 18 50 50        
    Fax:       +47 23 18 60 00
    Contact: Vice President Bjørn Fuglaas

  • GlaxoSmithKline AS

    Business focus

    Research-based pharmaceutical and healthcare company.

    Contact

    Pb. 180 Vinderen,
    NO-0319 Oslo.
    Phone: +47 22 70 20 51
    Fax:       +47 22 70 20 03 

    Contact: Medical director Olav Flaten

  • Lauras AS

    Business focus

    HIV therapy based on immune stimulation.

    Contact

    Gaustadalléen 21,
    NO-0349 Oslo.
    Phone: +47 22 95 86 98
    Fax:       +47 22 60 44 27

    Contact: CEO Birgit Stattin Norinder  

  • Lytix Biopharma AS

    Business focus

    Cancer and infectious diseases: Patented new drug candidates.

    Contact

    Sykehusveien 21/23,
    P.O. Box 6447,
    NO- 9294 Tromsø.
    Phone: +47 77 67 55 00
    Fax:       +47 77 67 55 01

    Contact: CEO Øystein Rekdal

  • Nycomed Norway Holding AS

    Business focus

    Nycomed was established in Norway by the pharmacist, Morten Nyegaard in 1874. The headquarter is located in  Zürich , Zwitzerland.  Nycomed is present  in  more than 50 countries worldwide and supplies more than 100  markets .  The company has 12 000 employees worldwide , and is one of the 25 largest pharmaceutical companies in the world.

     

    Nycomed  markets a differentiated portfolio focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management . In addition, Nycomed is a supplier of  OTC- medicines, vitamins and food supplements to pharmacies in selected markets.

     

    Nycomed  acquired  Altana in January 2007.  The  global revenue in 2008 amounted to  3. 3 billion Euro. In Norway, Nycomed has about 470 employees with production sites in Asker and Elverum. 

    Contact

    Postboks 205,
    1372 Asker,
    Norway,
    T +47 6676 3030
    General manager: Per S. Thoresen | +47 906 14 620
    Communications Director: Brita Sangolt | +47 911 80 646

     

     

     

     


  • Pfizer AS

    Business focus

    Each year, Pfizer pharmaceuticals help over 150 million people throughout the world live longer, healthier lives. With medicines across 11 therapeutic areas, we help to treat and prevent many of the most common, and most challenging, conditions of our time. We also build partnerships to help ensure access to our medicines and educate and empower consumers.

    Contact

    P.O. Box 3,
    NO-1324 Lysaker.
    Phone: +47 67 52 61 03
    Fax:       +47 67 52 61 99 

    Contact: Torfinn Hansen

  • Pronova Biopharma AS

    Business focus

    Pronova BioPharma is a global leader in the research, development and manufacture of marine-originated omega-3 derived pharmaceutical products. Core activities are founded upon marine-oil extracting and manufacturing traditions dating back to the 1900s.

    Contact

    P.O. Box 420,
    NO-1327 Lysaker.
    Phone: +47 22 53 48 50
    Fax:       +47 22 53 48 51 

    Contact: Gunnar Berge

  • Rheumatech AS

    Business focus

    Rheumatech AS has identified and patented the gene/protein Cbeta2 and its function. Cbeta2 is expressed (found) in immune cells (leucocyte or T- and B cells) which are crucial in the process of making the body respond optimally against infections and diseases.

    Contact

    Forskningsveien 2A,
    PO Box 180 Vinderen;
    NO-0319 Oslo. 
    Phone: +47 92 88 58 83

    Contact: Eirik Næss-Ulseth 

  • Sanofi-aventis Norge AS

    Business focus

    Sanofi- aventis is Europe's largest, and one of the world's leading pharmaceutical companies.

    The global headquarters is in Paris, and we are 70 employees in Norway. Focused on patients needs, sanofi-aventis offers a range of essential healthcare assets, including a broad-based product portfolio. Our biggest therapeuticall areas are oncology, diabetes, cardiovascular disease  and the central nervous system  In addition , we are a growing supplier in consumer healthcare and prescription-free medicines.

    Contact

    Strandveien 15
    Postboks 133
    1366 Lysaker
    Phone: +47 67 10 71 00/36
    Fax:      +47 67 10 71 01

    Contact: Annelene Svingen



     

     

  • SantoSolve AS

    Business focus

    SantoSolve AS develops novel drugs based on non-radioactive strontium. The company’s lead product is currently in phase III for two different pain indications.

    Contact

    Drammensveien 41,
    NO- 0271 Oslo.
    Phone:                +47 21 378 202        

    Contact: CEO Thorfinn Ege 

  • siRNAsense

    Business focus

    siRNAsense is a Norwegian biotechnology company, focussing on the first critical steps in developing therapeutics based on RNAi technology.

    Contact

    Gaustadallèen 21,
    NO-0349 Oslo.
    Phone: +47 22 95 81 92
    Fax:       +47 22 60 44 27

    Contact: R&D director: Dr. Mohammed Amarzguioui  

  • Smartfish AS

    Business focus

    Smartfish develops advanced nutritional compositions for improving cell functions and treating underlying mechanisms in disease.

    Contact

    Hoffsveien 65 A,
    NO-0377 Oslo

    P.O.Box 77 Smestad,
    NO-0309 Oslo

    Phone: +47 22 51 98 80
    Fax:     +47 22 51 98 81
    Contact : Jens Nordahl

  • Spermatech AS

    Business focus

    Spermatech AS is a pioneer in the development of non-hormonal drugs to regulate sperm motility for the purpose of contraception. Our primary focus is to discover and develop a novel small molecule male anti-fertility agent.

    Contact

    Forskningsveien 2A,
    PO Box 180 Vinderen;
    NO-0319 Oslo.
    Phone: +47 92 88 58 83
    Contact: Eirik Næss-Ulseth

  • Weifa AS

    Business focus

    Pharmaceutical company -- specializing in pharmaceuticals and fine chemicals for the world markets. 

    Contact

    P.O. 9113 Grønland,
    NO-0133 Oslo.
    Phone: +47 22 99 86 00
    Fax:       +47 22 99 86 01

    Contact: Director of business development, Halvor Weider

Norwegian Bioindustry Association

Middelthuns gt. 27, Postboks 7072 Majorstuen, NO-0306 Oslo Tel: +47 23 08 88 00 / +47 23 08 88 18 / +47 91 10 54 91 Email: biotek@norskindustri.no Fax: +47 23 08 88 98